Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125536121 | 12553612 | 1 | I | 201603 | 20160707 | 20160713 | 20160713 | EXP | FR-GILEAD-2016-0222799 | GILEAD | 46.00 | YR | A | F | Y | 0.00000 | 20160713 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125536121 | 12553612 | 1 | PS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, QD | 9 | DF | 21752 | 1 | DF | TABLET | QD | ||||
| 125536121 | 12553612 | 2 | SS | TIVICAY | DOLUTEGRAVIR SODIUM | 1 | Oral | 100 MG, QD | 900 | MG | 0 | 100 | MG | QD | |||||
| 125536121 | 12553612 | 3 | SS | LAROXYL | AMITRIPTYLINE | 1 | Oral | 50 MG, BID | 0 | 50 | MG | BID | |||||||
| 125536121 | 12553612 | 4 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, BID | 0 | 75 | MG | BID | |||||||
| 125536121 | 12553612 | 5 | SS | NORVIR | RITONAVIR | 1 | Oral | 200 MG, BID | 3600 | MG | 0 | 200 | MG | BID | |||||
| 125536121 | 12553612 | 6 | SS | APTIVUS | TIPRANAVIR | 1 | Oral | 250 MG, UNK | 0 | 250 | MG | ||||||||
| 125536121 | 12553612 | 7 | SS | IMOVANE | ZOPICLONE | 1 | Oral | 7.5 MG, QD | 0 | 7.5 | MG | QD | |||||||
| 125536121 | 12553612 | 8 | SS | THERALENE | TRIMEPRAZINE | 1 | Oral | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 125536121 | 12553612 | 9 | SS | TERCIAN /00759301/ | CYAMEMAZINE | 1 | Oral | UNK | 0 | ||||||||||
| 125536121 | 12553612 | 10 | C | LYSANXIA | PRAZEPAM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125536121 | 12553612 | 1 | Acquired immunodeficiency syndrome |
| 125536121 | 12553612 | 2 | Acquired immunodeficiency syndrome |
| 125536121 | 12553612 | 3 | Depression |
| 125536121 | 12553612 | 4 | Depression |
| 125536121 | 12553612 | 5 | Acquired immunodeficiency syndrome |
| 125536121 | 12553612 | 6 | Acquired immunodeficiency syndrome |
| 125536121 | 12553612 | 7 | Insomnia |
| 125536121 | 12553612 | 8 | Depression |
| 125536121 | 12553612 | 9 | Depression |
| 125536121 | 12553612 | 10 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125536121 | 12553612 | OT |
| 125536121 | 12553612 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125536121 | 12553612 | Completed suicide | |
| 125536121 | 12553612 | Depression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125536121 | 12553612 | 1 | 20160314 | 20160323 | 0 | |
| 125536121 | 12553612 | 2 | 20160314 | 20160323 | 0 | |
| 125536121 | 12553612 | 3 | 201511 | 20160323 | 0 | |
| 125536121 | 12553612 | 4 | 201504 | 20160323 | 0 | |
| 125536121 | 12553612 | 5 | 20160314 | 20160323 | 0 | |
| 125536121 | 12553612 | 6 | 2013 | 20160323 | 0 | |
| 125536121 | 12553612 | 7 | 201504 | 20160323 | 0 | |
| 125536121 | 12553612 | 8 | 20160323 | 0 | ||
| 125536121 | 12553612 | 9 | 20160323 | 0 |